Navigation Links
ForteBio Launches Two Revolutionary High-Throughput, Label-Free Instruments: The Octet(R) RED384 and the Octet QK384
Date:6/22/2009

MENLO PARK, Calif., June 22 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, announced today that it has launched two next-generation instruments: the Octet RED384 for protein, peptide, small molecule and fragment screening; and the Octet QK384 for protein and antibody assays. The new instruments will debut this week at the 2009 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology conference in Seattle, Washington, and will provide life science researchers with unprecedented throughput, speed, flexibility and cost-efficiency when using the company's Octet platform.

The Octet RED384 and the Octet QK384 will enable 384-well detection, 16-channel simultaneous readout, biosensor regeneration and re-racking, and automation capabilities for biotherapeutic and pharmaceutical drug discovery assays. The new instruments will increase the cost-efficiencies of running ForteBio's label-free Dip and Read(TM) biosensor assays in high-throughput mode, while enabling faster time-to-result for kinetic characterization and quantitation measurements.

"The Octet RED384 and Octet QK384 will deliver revolutionary efficiency improvements for life science research applications that have traditionally been conducted using ELISA or SPR-based methods," said Christopher Silva, ForteBio's vice president of marketing. "For example, using our new instrumentation, IgG titer determination can be completed in less than 20 minutes, as opposed to four to five hours using traditional ELISA methods. This fast time-to-result is important for bioprocess and cell line development researchers because it will enable them to monitor their bioreactors and fermentation cultures in real time. Additionally, our new label-free instruments enable researchers to perform protein kinetic screening and characterization on a 384-well plate in about two hours. These analyses have traditionally been conducted using SPR systems, which provide lower throughput and are substantially more expensive than the new Octet 384 series instruments."

The new systems support two 384- or 96-well plate positions and enable a full complement of samples to be run in one plate, while the second plate holds buffers, diluents and controls. The system is also capable of regeneration and re-racking of biosensors. Online biosensor regeneration drives the cost per sample down while conserving valuable ligand. Re-racking of used biosensors allows for optional offline regeneration and flexible assay methods, freeing up valuable instrument time to run more assays. The Octet 384 series instruments enable competitively low running cost in the 10-20 cents range per data point for quantitation and kinetic characterization assays.

The new systems are supported by Version 6 Octet software for data acquisition and analysis, which includes significant enhancements such as a 2:1 heterogeneous ligand binding model, data tracking and processing capabilities that assist in high-throughput screening. The new systems also include hardware and software robotic integration capabilities that support automation and database connectivity and can be licensed with optional 21 CFR Part 11 compliance tools.

ForteBio's Octet biosensors are disposable and are configured in a standard microplate format. Its biosensors simplify quantitation and kinetic characterization by eliminating throughput limitations of traditional SPR-based systems. Octet biosensors are coated with a proprietary biocompatible matrix that is uniform, non-denaturing and has minimal non-specific binding.

ForteBio also announced that the first batch of systems have been purchased by leading pharmaceutical and biotechnology companies after successful evaluations at customer sites.

About ForteBio, Inc.

ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio's analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit www.fortebio.com.


'/>"/>
SOURCE ForteBio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ForteBio, Inc. Closes $25 Million In Series C Financing
2. ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. Novozymes Launches Enzyme to Reduce Acrylamide in Food
5. Enova Medical Launches Exos Corporation
6. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
7. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
8. ThirdBiotech Networking Group Launches
9. BioReliance Launches Next-Generation Genotoxicity Screening Service
10. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
11. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... Meister Media Worldwide launches ... look and added functionality give the agricultural world a taste of Meister Media ... in agriculture – from precision farming via satellites and Unmanned Aerial Vehicles (UAVs) ...
(Date:4/29/2016)... (PRWEB) , ... April 30, 2016 , ... The MIT ... textile design, the bioLogic team explored how bacterial properties can be applied to fabric ... using Natto bacteria, which move in response to humidity change. The team harvested Natto ...
(Date:4/29/2016)... , April 29, 2016 ... Transparency Market Research "Separation Systems for Commercial Biotechnology ... Trends, and Forecast 2015 - 2023", the separation ... US$ 10,665.5 Mn in 2014 and is projected ... 2015 to 2023 to reach US$ 19,227.8 Mn ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intelligent Implant Systems announced ... FDA via 510(k) for sale in the United States. These components expand the ... fusions. With one-level sales beginning in October of 2015, the company has seen ...
Breaking Biology Technology:
(Date:3/10/2016)... March 10, 2016   Unisys Corporation (NYSE: ... Protection (CBP) is testing its biometric identity solution at ... to help identify certain non-U.S. citizens leaving the ... test, designed to help determine the efficiency and accuracy of ... February and will run until May 2016. --> ...
(Date:3/9/2016)... March 9, 2016  Crossmatch ® , a ... solutions, today announced the addition of smart features ... multi-factor authentication platform. New contextual and application-specific ... step-up security where it,s needed most — while ... DC . --> Washington, ...
(Date:3/3/2016)... 3, 2016  2016FLEX, organized by FlexTech, a ... advancements in flexible, hybrid and printed electronics. More ... - have gathered for short courses, technical session, ... electronics. The Flex Conference celebrates its 15 th ... R&D organizations, and universities contributing to the adoption ...
Breaking Biology News(10 mins):